Please login to the form below

Not currently logged in

Alzheimer's drug treatment

This page shows the latest Alzheimer's drug treatment news and features for those working in and with pharma, biotech and healthcare.

Biogen’s Alzheimers treatment Aduhelm limited to clinical trial participants in the US

Biogen’s Alzheimer’s treatment Aduhelm limited to clinical trial participants in the US

Following a thorough analysis, CMS discovered that although Aduhelm had the potential to help patients with Alzheimer's disease, the drug also had the potential to cause harm. ... Echoing Biogen’s comments, Harry Johns, chief executive officer of the

Latest news

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....